Insulin resistance as a risk factor for metabolic-associated fatty liver disease (MAFLD) in non-obese individuals | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 3, Issue 2, October 2023 PDF (789.17 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2023.456188 | ||
| Abstract | ||
| Metabolic associated liver disease (MAFLD) formally known as nonalcoholic faty liver disease (NAFLD) affects about 20% to 30% of the global population and increases the risk for hepatic and extrahepatic complications, including cardiovascular disease, diabetes, and some types of cancer | ||
|
Statistics Article View: 36 PDF Download: 12 |
||
